Skip to main content
SpringerLink
Log in

Managing chronic stable angina needs understanding of the benefits or various treatment options

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Staniforth AD. Contemporary management of chronic stable angina. Drugs Aging 2001; 18(2): 109–121

    Article  PubMed  CAS  Google Scholar 

  2. British National Formulary. No. 41. London. The Pharmaceutical Press, 2001 Mar

  3. Nidorf SM, Parsons RW, Thompson PL et al. Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction. BMJ. 1990 Jan 13; 300(6717): 71–4

    Article  PubMed  CAS  Google Scholar 

  4. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994 Aug; 90(2): 762–8

    Article  PubMed  CAS  Google Scholar 

  5. von Arnim T. Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. J Am Coll Cardiol 1995 Jan; 25(1): 231–8

    Article  Google Scholar 

  6. Fueberg, CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995 Sep 1; 92(5): 1326–31

    Article  Google Scholar 

  7. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988 Aug 18; 319(7): 385–92

    Article  Google Scholar 

  8. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II—DAVIT II). Am J Cardiol 1990 Oct 1; 66 (10): 779-85

  9. Total Ischaemic Burden European Trial (TIBET) study group. Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 1996 Jan; 17(1): 104–12

    Article  Google Scholar 

  10. Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996 Jan; 17(1): 76–81

    Article  PubMed  CAS  Google Scholar 

  11. GISSI-3: effects of Lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. Lancet 1994 May 7; 343(8906): 1115–22

    Google Scholar 

  12. ISIS-4: a randomised factorial trial assessing early oral Captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995 Mar 18; 345 (8951): 669-85

  13. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994 Oct; 90(4): 2056–69

    Article  PubMed  CAS  Google Scholar 

  14. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 Jan 20; 342(3): 145–53

    Article  PubMed  CAS  Google Scholar 

  15. ACIP investigators. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997 Apr 15; 95(8): 2037–43

    Article  Google Scholar 

  16. Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992 Jan 2; 326(1): 10–6

    Article  Google Scholar 

  17. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997 Aug 16; 350(9076): 461–8

    Article  Google Scholar 

  18. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992 Dec 12; 340(8833): 1421–5

    Article  Google Scholar 

  19. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996 Nov 16; 348(9038): 1329–39

    Article  Google Scholar 

  20. Illingworth DR. Management of hypercholesterolemia. Med Clin North Am 2000; 84(1): 23–42

    Article  PubMed  CAS  Google Scholar 

  21. Atorvastatin versus Revascularization Treatment Investigators. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999 Jul 8; 341(2): 70–6

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Managing chronic stable angina needs understanding of the benefits or various treatment options. Drugs Ther. Perspect 17, 10–15 (2001). https://doi.org/10.2165/00042310-200117170-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117170-00003

Keywords

Search

Navigation